144 related articles for article (PubMed ID: 12964966)
1. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer.
Brunaud L; Zarnegar R; Wada N; Magrane G; Wong M; Duh QY; Davis O; Clark OH
Thyroid; 2003 Jul; 13(7):621-9. PubMed ID: 12964966
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Wada N; Duh QY; Miura D; Brunaud L; Wong MG; Clark OH
J Clin Endocrinol Metab; 2002 Oct; 87(10):4595-601. PubMed ID: 12364440
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
Moses W; Weng J; Kebebew E
Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
Robenshtok E; Tzvetov G; Grozinsky-Glasberg S; Shraga-Slutzky I; Weinstein R; Lazar L; Serov S; Singer J; Hirsch D; Shimon I; Benbassat C
Thyroid; 2011 Jan; 21(1):43-8. PubMed ID: 20954815
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer.
Vriens MR; Suh I; Moses W; Kebebew E
Thyroid; 2009 Dec; 19(12):1343-9. PubMed ID: 20001717
[TBL] [Abstract][Full Text] [Related]
6. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
7. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
Singh B; Lim D; Cigudosa JC; Ghossein R; Shaha AR; Poluri A; Wreesmann VB; Tuttle M; Shah JP; Rao PH
Surgery; 2000 Dec; 128(6):888-93;discussion 893-4. PubMed ID: 11114620
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide appraisal of thyroid cancer progression.
Wreesmann VB; Ghossein RA; Patel SG; Harris CP; Schnaser EA; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Am J Pathol; 2002 Nov; 161(5):1549-56. PubMed ID: 12414503
[TBL] [Abstract][Full Text] [Related]
9. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas.
Roque L; Rodrigues R; Pinto A; Moura-Nunes V; Soares J
Genes Chromosomes Cancer; 2003 Mar; 36(3):292-302. PubMed ID: 12557229
[TBL] [Abstract][Full Text] [Related]
10. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
11. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
[TBL] [Abstract][Full Text] [Related]
12. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings.
Navas-Carrillo D; Ríos A; Rodríguez JM; Parrilla P; Orenes-Piñero E
Biochim Biophys Acta; 2014 Dec; 1846(2):468-76. PubMed ID: 25218916
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
Tanner MM; Karhu RA; Nupponen NN; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola JJ
Am J Pathol; 1998 Jul; 153(1):191-9. PubMed ID: 9665480
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up.
Sippel RS; Caron NR; Clark OH
World J Surg; 2007 May; 31(5):924-33. PubMed ID: 17429563
[TBL] [Abstract][Full Text] [Related]
15. Familial non-medullary thyroid cancer: a matched-case control study.
Maxwell EL; Hall FT; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
[TBL] [Abstract][Full Text] [Related]
16. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F
Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.
Miura D; Wada N; Chin K; Magrane GG; Wong M; Duh QY; Clark OH
Thyroid; 2003 Mar; 13(3):283-90. PubMed ID: 12729478
[TBL] [Abstract][Full Text] [Related]
18. The familial counterparts of follicular cell--derived thyroid tumors.
Prazeres H; Torres J; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2010 Aug; 18(4):233-42. PubMed ID: 20444727
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization.
Frisk T; Kytölä S; Wallin G; Zedenius J; Larsson C
Genes Chromosomes Cancer; 1999 Aug; 25(4):349-53. PubMed ID: 10398428
[TBL] [Abstract][Full Text] [Related]
20. An update on familial nonmedullary thyroid cancer.
Ammar SA; Alobuia WM; Kebebew E
Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]